←
The Koo Lab | IBS CGE1,043 posts
The Koo Lab | IBS CGE avatar

The Koo Lab | IBS CGE

@koo_lab

Koo Lab at IBS | Organoids, mosaic genetics & genome engineering | Stem cells, regeneration & cancer | Led by Bon-Kyoung Koo

◷ Joined May 2019▧ 140 Photos and videos
The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Nov 6

7/7 I expect to see more of this in our lab: colleagues becoming independent, new colleagues helping bring longstanding projects to completion, and collaborations continuing across borders. Thank you to everyone who contributed to this nearly seven-year journey!

The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Nov 6

6/7 Gabriele Colozza began this work with me as a postdoc in Vienna. He is now an assistant professor, and I encouraged him to take the last-author position. I am once again the penultimate author and a co-corresponding author.

The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Nov 6

5/7 First author Dr. Dong Woo Seo joined our lab this year and proved to be an outstanding “closing pitcher,” driving the final phase of this long-running project. Completing a study takes its own combination of insight, persistence, and skill.

The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Nov 6

4/7 WNK inhibition suppressed growth of mouse intestinal organoids carrying a PTPRK–RSPO3 fusion. In cell assays, it partially restored WNT-suppressive activity of the RNF43 I48T mutant. These preclinical findings motivate further work in selected genetic contexts.

The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Nov 6

3/7 Inhibiting WNK increased surface RNF43, promoted Frizzled receptor internalization, and reduced WNT signaling. This suppression disappeared in cells and organoids lacking both RNF43 and ZNRF3. The brake needs to be present for this approach to work.

The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Nov 6

2/7 WNT helps maintain intestinal stem cells and renew tissues. When dysregulated, it can contribute to cancer. RNF43 limits WNT signaling by removing its receptors from the cell surface. Our question: what controls this brake?

The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Aug 19

We are not simply looking for strong CVs. We are looking for scientists whose work could become a new field 10 years from now. Deadline: 30 Sept 2026

The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Aug 19

, and mature IBS Centers can reach roughly US$3–5M/year, depending on scientific scope and evaluation. This is not just another grant. It is a chance to build your own team, infrastructure, and long-term research program with substantial scientific autonomy.

The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·Aug 19

IBS is recruiting Early Career Directors—scientists, typically in their late 30s–early 40s, who are already creating a scientific direction of their own. The scale is unusual: roughly US$1M/year at the early-career level, with start-up/equipment support. ibs.re.kr/eng/sub04_10.do

Hans Clevers avatar
⟳ The Koo Lab | IBS CGE retweeted
Hans Clevers@HansClevers·Jun 17

Organoid researchers!! Save the date for the annual "Organoids are Us"-symposium. Held at the Beatrix Theater in the center of beautiful historic Utrecht. Venue is a 20 minute train ride from Schiphol Airport Amsterdam. Program will follow shortly.

Post attachment
The Koo Lab | IBS CGE avatar
The Koo Lab | IBS CGE@koo_lab·May 15

Short Conditional Intron: We first introduced SCON in EMM (2022), applied it to mosaic genetics in Nat Comm (2024), and now show in NAR (2026) that it works broadly, from fish to mouse to human cells. doi.org/10.1093/nar/gkag480